Payments to Acquire Property, Plant, and Equipment of Amneal Pharmaceuticals, Inc. from 31 Dec 2016 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Amneal Pharmaceuticals, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2016 to 31 Dec 2025.
  • Amneal Pharmaceuticals, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $13,162,000, a 43% increase year-over-year.
  • Amneal Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $70,063,000, a 35% increase from 2024.
  • Amneal Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $51,924,000, a 20% increase from 2023.
  • Amneal Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $43,216,000, a 6.9% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Amneal Pharmaceuticals, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $70,063,000 +$18,139,000 +35% 01 Jan 2025 31 Dec 2025 10-K 27 Feb 2026 2025 FY
2024 $51,924,000 +$8,708,000 +20% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2026 2025 FY
2023 $43,216,000 -$3,191,000 -6.9% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2026 2025 FY
2022 $46,407,000 -$1,321,000 -2.8% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025 2024 FY
2021 $47,728,000 -$8,717,000 -15% 01 Jan 2021 31 Dec 2021 10-K 14 Mar 2024 2023 FY
2020 $56,445,000 +$9,264,000 +20% 01 Jan 2020 31 Dec 2020 10-K 03 Mar 2023 2022 FY
2019 $47,181,000 -$35,907,000 -43% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 $83,088,000 -$11,683,000 -12% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021 2020 FY
2017 $94,771,000 -$27,985,000 -23% 01 Jan 2017 31 Dec 2017 10-K 02 Mar 2020 2019 FY
2016 $122,756,000 01 Jan 2016 31 Dec 2016 10-K 01 Mar 2019 2018 FY

Amneal Pharmaceuticals, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $13,162,000 +$3,964,000 +43% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q1 2024 $9,198,000 -$490,000 -5.1% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q1 2023 $9,688,000 -$1,105,000 -10% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q1 2022 $10,793,000 -$983,000 -8.3% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q1 2021 $11,776,000 +$4,409,000 +60% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q1 2020 $7,367,000 -$10,621,000 -59% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021 2021 Q1
Q1 2019 $17,988,000 -$1,511,000 -7.7% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q1 2018 $19,499,000 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.